Biopsy Market Trends, Research Report, Growth, Opportunities, Forecast 2029

Comments · 78 Views

North America is expected to hold the highest share in the Global Biopsy Market.

The Report Biopsy Market by Product (Instruments, Kits and Consumables, Services) , by Type ( Tissue Biopsies, Liquid Biopsies, Others ) and by Application ( Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Liver Cancers, Pancreatic Cancers, Ovarian Cancers, Others) The increasing adoption of Biopsy Market as a sustainable and high-performance material drives its market growth.

The global Biopsy Market is on track to achieve significant growth, with a projected Biopsy Market size is expected to grow from US$ 29.14 Bn. in 2022 to US$ 61.03 Bn. by 2029, growing at a CAGR of 11.14% through 2023 to 2029. Kits and Consumables Product segment leads the Global Biopsy Market by 2029.

Application segment with the quickest growth

The market is divided into many categories depending on the application: Breast cancer, colorectal cancer, cervical cancer, lung cancer, prostate cancer, skin cancer, blood cancer, kidney cancer, liver cancer, pancreatic cancer, ovarian cancer, and others. The breast cancer segment is anticipated to expand quickly at a CAGR from 2023 to 2029. The most common type of cancer is breast cancer. One in eight women in the United States may get invasive breast cancer, according to the latest data. In the US, more than 40,000 new cases of non-invasive breast cancer would be detected in 2021, with an estimated 276,480 new cases of invasive breast cancer being diagnosed in women.

A precise diagnosis, as well as the stage and type, must be determined through microscopic examination of breast tissue in the growing number of people suspected of having breast cancer. As a result, there is a greater need for a surgical or needle biopsy to get tissue for microscopic examination, which is driving sector growth.

 

For detail insights on this market, request for methodology here @https://www.maximizemarketresearch.com/request-sample/116684

Instruments, Kits and Consumables, and Services segments based on the type of Product in Biopsy Market

The market is divided into Instruments, Kits and Consumables, and Services based on the Product. In 2022, the Kits and Consumables sector had the biggest market share (60.0%), and it is anticipated that this dominance will last through 2029. This is because different stages of biopsies require different kits and consumables. The expansion of the category has also been greatly aided by sizable investments made by key players in the market. The rise in this market sector might also be attributed to an increase in the number of patients who want rapid, accurate, and efficient equipment and kits on a global scale.

North America region is positioned as a frontrunner in the Biopsy Market

The Global Biopsy Market is dominated by North America from 2023 to 2029. 40% of the global market was accounted for by North America in 2022, and this dominance is anticipated to persist until 2029. The region is anticipated to keep up its lead during the projected period, with the United States contributing significantly to regional revenue. The market for cancer biopsies in the US is anticipated to grow at a CAGR of 11.0% from 2017 to 2029, reaching USD 19.68 billion. One of the main factors influencing the market is the rising usage of technologically advanced equipment for early illness diagnosis. Distributors and producers in this region are also attempting to develop new kits that are appropriate for use in quick diagnostic applications.

Biopsy Market Key Players:

1. Qiagen N.V. 2. Illumina, Inc. 3. ANGLE Plc 4. BD (Becton, Dickinson and Company) 5. Myriad Genetics 6. Hologic, Inc. 7. Biocept, Inc. 8. Thermo Fisher Scientific, Inc. 9. Danaher 10.F. Hoffmann-La Roche Ltd. 11. Lucence Diagnostics Pte. Ltd. 12. GRAIL, Inc. 13. Guardant Health 14. Exact Sciences Corporation 15. Freenome Holdings, Inc. 16. Biodesix (Integrated Diagnostics) 17. Oncimmune 18. Epigenomics AG 19. HelioHealth (Laboratory for Advanced Medicine) 20. Genesystems, Inc. (Genesys Biolabs)

For More Information About This Research Please Visit :https://www.maximizemarketresearch.com/market-report/global-biopsy-market/116684/

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Maximize Market Research:

MAXIMIZE MARKET RESEARCH PVT. LTD.

⮝ 444 West Lake Street, Floor 17,

Chicago, IL, 60606, USA.

✆ +1 800 507 4489

✆ +91 9607365656

? sales@maximizemarketresearch.com

? www.maximizemarketresearch.com

Related Report :

Cell Culture Market https://www.maximizemarketresearch.com/market-report/global-cell-culture-market/33004/


Digital Pen Market https://www.maximizemarketresearch.com/market-report/global-digital-pen-market/33503/


Global Organic Food Market https://www.maximizemarketresearch.com/market-report/global-organic-food-market/87324/

Comments